Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $62.00
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its price objective upped by investment analysts at Needham & Company LLC from $46.00 to $62.00 in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential […]
More Stories
Radix Price Tops $0.0157 (XRD)
Radix (XRD) traded up 1.3% against the U.S. dollar during the twenty-four hour period ending at 22:00 PM E.T. on...
Basilea Pharmaceutica (OTCMKTS:BPMUF) Hits New 1-Year High – Time to Buy?
Shares of Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday...
FUNToken (FUN) Price Tops $0.0032 on Top Exchanges
FUNToken (FUN) traded 2.3% higher against the U.S. dollar during the one day period ending at 22:00 PM Eastern on...
Short Interest in Carlyle Secured Lending, Inc. (NASDAQ:CGBD) Declines By 35.8%
Carlyle Secured Lending, Inc. (NASDAQ:CGBD – Get Free Report) was the target of a large drop in short interest in...
Terran Coin (TRR) Price Reaches $0.0004 on Exchanges
Terran Coin (TRR) traded down 0.6% against the U.S. dollar during the 1 day period ending at 22:00 PM ET...
IoTeX (IOTX) Self Reported Market Capitalization Achieves $402.14 Million
IoTeX (IOTX) traded 6.2% higher against the U.S. dollar during the 24 hour period ending at 22:00 PM E.T. on...